These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10616614)

  • 21. Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: effects on personality.
    Hellerstein DJ; Kocsis JH; Chapman D; Stewart JW; Harrison W
    Am J Psychiatry; 2000 Sep; 157(9):1436-44. PubMed ID: 10964860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-blind multicenter trial comparing sertraline and citalopram in patients with major depression treated in general practice.
    Ekselius L; von Knorring L; Eberhard G
    Int Clin Psychopharmacol; 1997 Nov; 12(6):323-31. PubMed ID: 9547134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A claims analysis comparing citalopram with sertraline as initial pharmacotherapy for a new episode of depression: impact on depression-related treatment charges.
    McLaughlin TP; Eaddy MT; Grudzinski AN
    Clin Ther; 2004 Jan; 26(1):115-24. PubMed ID: 14996524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Which SSRIs most effectively treat depression in adolescents?
    DeLucia V; Kelsberg G; Safranek S
    J Fam Pract; 2016 Sep; 65(9):632-4. PubMed ID: 27672691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: a randomized trial.
    Kroenke K; West SL; Swindle R; Gilsenan A; Eckert GJ; Dolor R; Stang P; Zhou XH; Hays R; Weinberger M
    JAMA; 2001 Dec; 286(23):2947-55. PubMed ID: 11743835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
    Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD011681. PubMed ID: 25931277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of first refill rates among users of sertraline, paroxetine, and citalopram.
    Mullins CD; Shaya FT; Meng F; Wang J; Bron MS
    Clin Ther; 2006 Feb; 28(2):297-305; discussion 296. PubMed ID: 16678651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Escitalopram versus sertraline in the treatment of major depressive disorder: a randomized clinical trial.
    Ventura D; Armstrong EP; Skrepnek GH; Haim Erder M
    Curr Med Res Opin; 2007 Feb; 23(2):245-50. PubMed ID: 17288677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SSRIs do not worsen Parkinson's disease: evidence from an open-label, prospective study.
    Dell'Agnello G; Ceravolo R; Nuti A; Bellini G; Piccinni A; D'Avino C; Dell'Osso L; Bonuccelli U
    Clin Neuropharmacol; 2001; 24(4):221-7. PubMed ID: 11479393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A pooled analysis of six month comparative efficacy and tolerability in four randomized clinical trials: agomelatine versus escitalopram, fluoxetine, and sertraline.
    Demyttenaere K; Corruble E; Hale A; Quera-Salva MA; Picarel-Blanchot F; Kasper S
    CNS Spectr; 2013 Jun; 18(3):163-70. PubMed ID: 23472671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mood and personality effects in healthy participants after chronic administration of sertraline.
    Simmons JG; Allen NB
    J Affect Disord; 2011 Nov; 134(1-3):377-85. PubMed ID: 21724265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotonergic Regulation and Cognition after Stroke: The Role of Antidepressant Treatment and Genetic Variation.
    Damsbo AG; Kraglund KL; Buttenschøn HN; Johnsen SP; Andersen G; Mortensen JK
    Cerebrovasc Dis; 2019; 47(1-2):72-79. PubMed ID: 30844812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is selectivity for serotonin uptake associated with a reduced emergence of manic episodes in depressed patients?
    Barak Y; Kimhi R; Weizman R
    Int Clin Psychopharmacol; 2000 Jan; 15(1):53-6. PubMed ID: 10836288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome.
    Tack J; Broekaert D; Fischler B; Van Oudenhove L; Gevers AM; Janssens J
    Gut; 2006 Aug; 55(8):1095-103. PubMed ID: 16401691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of baseline severity on the effects of SSRIs in depression: an item-based, patient-level post-hoc analysis.
    Hieronymus F; Lisinski A; Nilsson S; Eriksson E
    Lancet Psychiatry; 2019 Sep; 6(9):745-752. PubMed ID: 31303567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Citalopram versus fluoxetine for the treatment of patients with bulimia nervosa: a single-blind randomized controlled trial.
    Leombruni P; Amianto F; Delsedime N; Gramaglia C; Abbate-Daga G; Fassino S
    Adv Ther; 2006; 23(3):481-94. PubMed ID: 16912031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression.
    Fava M; Rosenbaum JF; Hoog SL; Tepner RG; Kopp JB; Nilsson ME
    J Affect Disord; 2000 Aug; 59(2):119-26. PubMed ID: 10837880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sertraline versus paroxetine in major depression: clinical outcome after six months of continuous therapy.
    Aberg-Wistedt A; Agren H; Ekselius L; Bengtsson F; Akerblad AC
    J Clin Psychopharmacol; 2000 Dec; 20(6):645-52. PubMed ID: 11106136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression.
    Thase ME; Nierenberg AA; Vrijland P; van Oers HJ; Schutte AJ; Simmons JH
    Int Clin Psychopharmacol; 2010 Jul; 25(4):189-98. PubMed ID: 20531012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential indications for the selective serotonin reuptake inhibitors.
    Boyer WF
    Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 5():5-12. PubMed ID: 1431022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.